TCBP: TC BioPharm Ltd Sotuvga nisbatan narx
TC Biopharm (TCBP) kompaniyasining sotuvlarga nisbatan narx koeffitsiyenti dinamikasi allogeneik T-hujayra mahsulotlari sektorida patentlarning qiymatini ko'rsatadi, bunda 0.20 oxirgi metrika qiymatini aks ettiradi. Saratonni davolashning innovatsion usullarini ishlab chiqish rahbariyatning onkologiya sohasidagi tajribasiga tayanadi, gamma-delta terapiyalari bo'yicha faol tadqiqotlar va kutilayotgan test natijalari esa kompaniya jarayonlarining yuqori ilmiy intensivligini tasdiqlaydi.
%20Plc%3A%20Kapitalizatsiyaning%20daromadga%20nisbati&width=1200&height=400&colorIndex=0&v=mwejrfjc.e5f-7d7lczk&start=20220704&end=20261113&filename=GURU_Markets_-_TCBP_-_TC-Biopharm_-_Market-Cap-to-Revenue "TC BioPharm Ltd - TCBP Kapitalizatsiyaning sotish hajmiga nisbati (davr: 28.04.2023 - 30.09.2024) | 👁️GURU.Markets👁️")
TC BioPharm (Holdings) PLC (TCBP) kompaniyasining tahliliy kesimlari
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Barcha qarzlarning o‘z mablag‘lariga nisbati TC Biopharm|TCBP - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati TC BioPharm Ltd|TCBP - Kompaniyaning jamlangan qarzlari|Sof aktivlarga qarzlar TC BioPharm Ltd|TCBP - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz TC BioPharm|Kritik likvidlik koeffitsiyenti tcbiopharm.com
- foyda va bozor koeffitsiyentlari statistikasi:
TCBP - Sof foyda|Kutilayotgan sof daromad TC Biopharm|TCBP - P/E multiplikatori|Forvard P/E multiplikatori TC BioPharm (Holdings) Plc|TCBP - Narxning foydaga va o‘sish sur’atiga nisbati|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati TC BioPharm Ltd|TCBP - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bir aksiya uchun sof foyda TC BioPharm|TCBP - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sish sur'ati tcbiopharm.com|TCBP - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi TC Biopharm
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning umumiy tahlili:TCBP, tcbiopharm.com
Sotuvlar nisbatidagi narx koeffitsienti bozorning daromad birligi uchun to'lashga tayyor bo'lgan premiumini o'lchaydi va bu biznes qiymatiga nisbatan daromad keltirish samaradorligini baholash imkonini beradi. TC Biopharm (TCBP) uchun sotuvlar nisbatidagi narx koeffitsientining tahlili spekulyativ investorlar kutganlarini aks ettiradi, chunki T-hujayrali terapiyalarning tasdiqlanishidan keyingi kelajakdagi monopol narx belgilash imkoniyati kompaniyaning fundamental qiymatini tubdan o'zgartirishi mumkin.
TC Biopharm raqobatchilari
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA: Kapitalizatsiyaning daromadga nisbati|Protagonist Corp - Kapitalizatsiyaning sotish hajmiga nisbati|IMVT: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati kiniksa.com|Kapitalizatsiyaning daromadga nisbati GRFS|ADPT: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori CLDX|Narxning daromadga nisbati AUPH (Aurinia Corp)|P/S multiplikatori BCRX (BioCryst)|Narx/daromad koeffitsiyenti veratx.com (VERA)|DNTH - Narxning daromadga nisbati|Sotuvga nisbatan narx Pharvaris NV|AbCellera Biologics Inc (ABCL) - Narxning daromadga nisbati|Narxning sotuvga nisbati TRML (Tourmaline)|PGEN (Precigen, Inc.) - P/S multiplikatori|PHAR: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NKTR|P/S multiplikatori Upstream Bio, Inc. (UPB)|Narxning daromadga nisbati Zenas Biopharma, Inc. ZBIO|Bozor kapitallashuvining daromadga nisbati IMNM|GOSS - Narxning daromadga nisbati|kalvista.com (KALV) - Kapitalizatsiyaning daromadga nisbati|SEPN (Septerna) - Kapitalizatsiyaning daromadga nisbati|PVLA: Kapitalizatsiyaning sotish hajmiga nisbati|SVRA (Savara Corp) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Rigel Corp (RIGL)|P/S multiplikatori ANAB|Narxning daromadga nisbati ATXS (astriatx.com)|Narxning daromadga nisbati enGene ENGN|RAPT (RAPT Therapeutics Inc.) - Narxning sotuvga nisbati|JBIO - Narxning daromadga nisbati|Narxning sotuvga nisbati ACRS|KYTX: P/S multiplikatori|tizianalifesciences.com - Bozor kapitallashuvining daromadga nisbati|CABA (Cabaletta Bio) - P/S multiplikatori|P/S multiplikatori Ventyx Biosciences Inc.|Narxning daromadga nisbati Theratechnologies Inc (THTX)|AVTX (Avalo Therapeutics Inc) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Eledon Pharmaceuticals ELDN|AGEN - Kapitalizatsiyaning daromadga nisbati|Climb Bio - P/S multiplikatori|ZURA - P/S multiplikatori|ATYR (aTyr) - Kapitalizatsiyaning daromadga nisbati|Adagene Inc. - Bozor kapitallashuvining daromadga nisbati|IMA (ImageneBio) - P/S multiplikatori|Shattuck Therapeutics (STTK) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Equillium, Inc. (EQ)|Kapitalizatsiyaning daromadga nisbati connectbiopharm.com CNTB|Narxning daromadga nisbati Immunic IMUX|ATRA - Kapitalizatsiyaning daromadga nisbati|IFRX: Kapitalizatsiyaning daromadga nisbati|XFOR - P/S multiplikatori|adicetbio.com (ACET) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati CELU|INMB (INmune Bio Corp) - P/S multiplikatori|Sotuvga nisbatan narx Barinthus Biotherapeutics Corp BRNS|Kapitalizatsiyaning daromadga nisbati KZR (Kezar Life Sciences)|Kapitalizatsiyaning sotish hajmiga nisbati SABS|P/S multiplikatori AKTX (Akari Therapeutics Plc)|ENLV - Kapitalizatsiyaning daromadga nisbati|QTTB: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati GOVX (GeoVax Corp)|EDSA: P/S multiplikatori|IBIO (ibioinc.com) - Narxning daromadga nisbati|CARM (Carisma Therapeutics Inc) - P/S multiplikatori|XTL Biopharmaceuticals Ltd (XTLB) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Bolt Biotherapeutics (BOLT)|HCWB - Sotuvga nisbatan narx|Narxning daromadga nisbati Aptevo Therapeutics Inc. APVO|AIM (AIM ImmunoTech, Inc.) - Narxning sotuvga nisbati|Aditxt Corp - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati GRI (GRI Bio Inc)|XRTX: P/S multiplikatori|Vyome Therapeutics (HIND) - P/S multiplikatori|Narxning daromadga nisbati Revelation Biosciences|INDP: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Scinai Immunotherapeutics Ltd. (SCNI)|Kapitalizatsiyaning daromadga nisbati calcimedica.com CALI|Affimed N.V. - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati ALLK (Allakos Inc)|HOOKIPA - P/S multiplikatori|IGM Biosciences, Inc. (IGMS) - Kapitalizatsiyaning daromadga nisbati|ITOS: P/S multiplikatori|OCEA (Ocean Biomedical Inc) - Narxning daromadga nisbati|Narxning daromadga nisbati Third Harmonic Bio, Inc
